Syndax Pharma (SNDX)

Trade SNDX now with
6/28/2021 7:10:41 AM Syndax : SNDX-5613 Granted FDA Fast Track Designation For Treatment Of Relapsed/Refractory Acute Leukemias
4/15/2021 7:17:27 AM Syndax Pharma To Provide Updated Data From Phase 1 Portion Of AUGMENT-101 Trial Of SNDX-5613 On Apr 20
3/31/2021 7:08:06 AM Syndax: FDA Grants Orphan Drug Designation To Axatilimab For Patients With Chronic Graft Versus Host Disease
12/9/2020 6:32:14 AM Syndax Reports Pricing Of Public Offering Of 5.43 Mln Common Shares At $23/Shr
7/7/2020 7:08:47 AM Syndax Pharma Appoints Daphne Karydas As CFOr, Effective July 13
5/22/2020 10:21:35 AM Stock Alert: Synadax Down 18%
4/30/2020 7:55:08 AM Syndax Pharma Says Prices Underwritten Public Offering Of 5.55 Mln Shares At $18/shr
1/31/2020 7:08:19 AM Syndax Announces $35 Mln Offering Of Common Stock And Enters Term Sheet For Loan With Hercules Capital For $30 Mln
1/5/2018 1:22:41 PM B. Riley FBR Starts Syndax Pharma (SNDX) At Buy With $40.00 Price Target
3/16/2017 8:55:28 AM FBR Capital Markets Starts Syndax Pharma (SNDX) At Outperform With $27 Price Target